By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Collegium Pharmaceutical, Inc. 

400 Highland Corporate Drive

Cumberland  Rhode Island  02864  U.S.A.
Phone: 401-762-2000 Fax: 401-762-2043



Company News
Collegium (COLL) Announces Positive Topline Results Of Human Abuse Potential Clinical Trial Evaluating The Oral Abuse Of Xtampza ER 2/1/2017 7:25:02 AM
Collegium (COLL) Announces The Addition Of Xtampza ER To Express Scripts’ Formulary 12/15/2016 7:39:46 AM
Collegium (COLL) Announces Underwriters’ Exercise Of Option To Purchase Additional Shares 11/29/2016 8:10:36 AM
Collegium (COLL) Release: Independent Review Of Xtampza ER Published In Peer-Reviewed Medical Journal 11/21/2016 10:26:11 AM
Collegium (COLL) Reports Third Quarter Financial Results and Provides Corporate Update 11/11/2016 11:13:48 AM
Collegium (COLL) To Host Conference Call To Discuss Third Quarter 2016 Financial Results And Provide Corporate Update 11/3/2016 11:08:55 AM
Collegium (COLL) Prices Public Offering Of $80 Million Of Common Stock 10/26/2016 8:08:37 AM
Collegium (COLL) Announces Proposed Public Offering Of Common Stock 10/26/2016 8:07:46 AM
Collegium (COLL) Submits Supplemental New Drug Submission To FDA For Xtampza ER 10/5/2016 7:59:25 AM
Collegium (COLL) Submits New Drug Submission To Health Canada or Xtampza ER, An Analgesic With Abuse-Deterrent Properties For The Treatment Of Chronic Pain 10/3/2016 7:48:24 AM